Northeast Investment Management’s Elevance Health ELV Stock Holding History

Northeast Investment Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,554	Closed	-$677K	–	178
2023 Q3	$677K	Buy	1,554 +214	+16%	+$97.1K	0.04%	118
2023 Q2	$595K	Sell	1,340 -3	-0.2%	-$1.38K	0.03%	122
2023 Q1	$618K	Sell	1,343 -4	-0.3%	-$1.9K	0.04%	115
2022 Q4	$691K	Buy	1,347 +363	+37%	+$184K	0.04%	114
2022 Q3	$447K	Buy	984 +293	+42%	+$140K	0.03%	124
2022 Q2	$333K	Buy	691 +145	+27%	+$71.7K	0.02%	145
2022 Q1	$268K	Hold	546	–	–	0.01%	178
2021 Q4	$253K	Hold	546	–	–	0.01%	185
2021 Q3	$204K	Hold	546	–	–	0.01%	190
2021 Q2	$208K	Buy	+546	New	+$209K	0.01%	187

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northeast Investment Management's ELV Position: Q4 2023 in Review

Northeast Investment Management sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 1,554 shares — an estimated $677K sold.

Northeast Investment Management first reported a position in ELV in Q2 2021 and held it in 10 quarters. The position peaked at $691K in Q4 2022. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

Northeast Investment Management reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
Northeast Investment Management sold 1,554 Elevance Health shares in Q4 2023, an estimated $677K.
Northeast Investment Management first reported a position in Elevance Health in Q2 2021 and held it in 10 quarters.
Northeast Investment Management's Elevance Health position peaked at $691K in Q4 2022.
1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Northeast Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.